The week in health tech, explained in plain English.Get the free newsletter →
October 24, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Government

Trump Bought Tobacco Stocks as FDA Eased Industry Rules

President Donald Trump bought tobacco stocks and his political movement has been buoyed by a wave of industry donations as his administration pursued an extensive pro-tobacco agenda, according to federal records reviewed by KFF Health News.

The reporting connects the financial ties to a regulatory shift at the FDA, which has eased standards governing cigarettes and e-cigarettes. That combination raises questions about conflicts of interest at the top of the agency responsible for policing the products that kill hundreds of thousands of Americans each year. Public health advocates have long pushed for tighter limits on vaping and menthol products, and a relaxed posture cuts against that direction.

For the broader health industry, FDA tobacco policy sets the rules for product authorizations, marketing claims, and enforcement against illegal vapes. A friendlier regulatory environment changes the calculus for manufacturers and for the clinicians, payers, and public health programs that absorb the downstream costs of tobacco-related disease.

More in Government

Government

FDA Approves First Once-Weekly Insulin for Children

The FDA approved Novo Nordisk's Awiqli, the first once-weekly basal insulin for children 10 and older with Type 2 diabetes.

Why it matters: Weekly rather than daily insulin could improve adherence for a growing number of children with Type 2 diabetes.

Government

Feds Launch False Claims Act Self-Disclosure Pilot

HHS and the DOJ Civil Division have launched a six-month pilot letting healthcare companies self-report potential civil False Claims Act violations and settle through a coordinated civil release.

Why it matters: The pilot reshapes how hospitals and healthcare firms weigh self-reporting against federal fraud enforcement, with real consequences for compliance strategy.

Government

GOP Pushes Fraud Message to Deflect Healthcare Cost Anger

Republicans are elevating healthcare fraud as a midterm message to deflect voter anger over costs, while Democrats say the push targets blue states to justify Medicaid and ACA cuts.

Why it matters: Fraud-focused enforcement could reshape Medicaid and ACA funding, audits, and eligibility for the tens of millions who depend on those programs.